Related Experiment Video
Updated: Nov 5, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
DUXAP8 knockdown inhibits the development of melanoma by regulating the miR-3182/NUPR1 pathway
Xige Chen1, Juan Gao1, Ning Liang2
1Department of Dermatology, Weihai Central Hospital, Weihai, Shandong 264400, P.R. China.
Abstract:
Double homeobox A pseudogene 8 (DUXAP8) has been reported to regulate the growth of several types of cancers, such as breast cancer and ovarian cancer. However, its role in melanoma remains unclear. In the present study, the mechanism through which DUXAP8 regulates melanoma progression was explored. The expression levels of DUXAP8 were determined in 43 samples from patients with melanoma in different stages, as well as human epidermal melanocytes cells and malignant melanoma cell lines using reverse transcription-quantitative PCR (RT-qPCR). The prognosis of patients was analyzed using the Kaplan-Meier method. The relationship between lncRNA DUXAP8 expression and microRNA (miR)-3182 or nuclear protein 1 transcriptional regulator (NUPR1) levels was analyzed using Pearson's correlation. Luciferase reporter and RNA pull-down were used to examine the interactions between these molecules. Proliferation was assessed using Cell Counting-Kit-8. Transwell assays were used to examine cell migration and invasion. lncRNA DUXAP8 was upregulated in melanoma tissue and cells compared with normal tissues and cells. The levels of DUXAP8 inversely correlated with survival time of patients with melanoma. Knockdown of lncRNA DUXAP8 inhibited proliferation, migration and invasion of melanoma cells. lncRNA DUXAP8 targeted miR-3182, while miR-3182 targeted NUPR1. The overexpression of NUPR1 reversed the effects of DUXAP8 knockdown or miR-3182 mimic on melanoma progression. In conclusion, lncRNA DUXAP8 downregulation inhibits the development of melanoma by regulating the miR-3182/NUPR1 axis.
Insights
Double homeobox A pseudogene 8 (DUXAP8) promotes melanoma growth. Downregulating DUXAP8 inhibits cancer progression by affecting the miR-3182/NUPR1 pathway, offering a potential therapeutic target for melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The role of Double homeobox A pseudogene 8 (DUXAP8) in melanoma progression is not well understood.
- Previous studies indicate DUXAP8's involvement in other cancer types.
Purpose of the Study:
- To investigate the mechanism by which DUXAP8 influences melanoma progression.
- To explore the relationship between DUXAP8, miR-3182, and NUPR1 in melanoma.
Main Methods:
- Quantitative reverse transcription-PCR (RT-qPCR) for DUXAP8 expression analysis.
- Kaplan-Meier survival analysis and Pearson's correlation for prognostic and relational insights.
- Luciferase reporter assays, RNA pull-down, Cell Counting-Kit-8, and Transwell assays to elucidate molecular interactions and cellular behaviors.
Main Results:
- DUXAP8 was found to be upregulated in melanoma tissues and cells.
- Higher DUXAP8 levels correlated with shorter patient survival times.
- Knockdown of DUXAP8 suppressed melanoma cell proliferation, migration, and invasion.
- DUXAP8 targets miR-3182, which in turn targets NUPR1; NUPR1 overexpression counteracted DUXAP8 knockdown effects.
Conclusions:
- DUXAP8 acts as an oncogenic lncRNA in melanoma.
- Downregulation of DUXAP8 inhibits melanoma development via the miR-3182/NUPR1 axis.
- Targeting the DUXAP8/miR-3182/NUPR1 pathway presents a potential therapeutic strategy for melanoma.
More Related Videos
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Abnormal Proliferation